TY - JOUR T1 - Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Jazieh <em>et al</em> JF - Journal for ImmunoTherapy of Cancer JO - J Immunother Cancer DO - 10.1136/jitc-2022-004965 VL - 10 IS - 5 SP - e004965 AU - Jieling Zheng AU - Bin Zhang Y1 - 2022/05/01 UR - http://jitc.bmj.com/content/10/5/e004965.abstract ER -